英国伦敦大学学院刘朝宗副教授：骨关节炎早期介入治疗:机遇与挑战
日期：2018-04-09
浏览量：910
报告题目：骨关节炎早期介入治疗:机遇与挑战
报 告 人：刘朝宗（英国伦敦大学学院University College London，副教授）
报告时间：2017年12月19日（星期二）10:00-10:30
报告地点：大学城B12-410会议室
欢迎广大师生前往！
材料科学与工程学院
2017年12月15日
报告人简介：
Dr Chaozong Liu is an associate professor in Biomedical Engineering, the programme leader of MSc in Musculoskeletal Science, and the group leader of UCL Biomaterials & Osteochondral Tissue Engineering within the Division of Surgery & Interventional Science University College London. He has several years’ experience of biomaterials processing and development of medical devices. Dr Liu’s current research is directed toward the development of enhanced medical devices for treating musculoskeletal disorders, tissue repair and regeneration. This is a growing area of interest at UCL Surgical & Interventional Science. His research in this area is supported by ARUK, Innovate UK, Horizon2020, EPSRC MeDe Innovation Centre and RoseTree Trusts, and from Fitzpatrick Referrals Ltd. He has developed a new osteochondral scaffold technology that is likely to have a strong potential in regeneration of bone and cartilage for early intervention of osteoarthritis. Preclinical study has demonstrated that the new osteochondral scaffold has the strength needed to bear the physical load of the joints and its patented biomedical structure encourages consistent cartilage fill. A glimpse of how this scaffold will perform has been given, with promising results, by Professor Noel Fitzpatrick of the Channel 4 TV series Supervet, where it was implanted in a pet dog shoulder to treat a large osteochondral defect. His achievement on how bioengineering innovation could treat and prevent OA in Arthritis Today (Winter 2017, No 174). The recent awards from Innovate UK-MoST and EU HORIZON2020 have significantly boosted his research in this field.
报告摘要：
UCL is one of the global top research intensive universities on a research output dominated by its Biomedical and Engineering Faculties. UCL’s contribution to the programme will be led by Institute of Orthopaedics and Musculoskeletal Science (IOMS) which is an internationally leading Centre of research and postgraduate training. Its research straddling medical and bio-medical engineering applications. It has reputation and track record for innovative translation research, and has established expertise in technology transferring such as Stanmore Implant Worldwide. UCL and staffs from the Royal National Orthopaedic Hospital and other affiliated hospitals lead units of major importance in clinical care and are at the cutting edge of research and development in medical devices innovation, cell-engineering and rapid fabrication of tissues, as well as healthcare engineering. These have applications in musculoskeletal system rehabilitation and vascular regeneration. Based at University College London, we’re pioneering and developing the next generation of healthcare innovations, aiming to optimise treatment and improve the lives of patients across the globe. Our professional engineers and skilled clinicians work side by side to enhance existing methods of diagnosis, therapy and monitoring. UCL medical science provides a unique environment for collaboration between scientists, engineers, and clinicians in an Academic Health Sciences Centre model, in order to speed up the development of improvements in patient care.